ENTITY

Voyager Therapeutics (VYGR US)

Analysis

Health Care • United States

Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company. The Company focuses on developing life-changing treatments for patients suffering from severe diseases of the central nervous system. Voyager Therapeutics develops gene therapies for fatal and debilitating diseases.

Refresh

No presentations found

We’ll display presentations we find for Voyager Therapeutics here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00